Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Towa International

02 42care4

03 2ANFARM HELLAS S.A.

04 1Alkem Laboratories

05 1Allrite Group

06 5Amarox Pharma B.V

07 4Annora Pharma

08 10Apotex Inc

09 5Ascent Innovative Medicines

10 2Auro Pharma Inc

11 2Aurobindo Pharma Limited

12 5CENTAUR PHARMS PVT

13 5CLONMEL HLTHCARE

14 4Cinfa Laboratories Sa

15 5Cipla

16 11Desitin Arzneimittel

17 5GL Pharma

18 10GSK

19 5Glenmark Pharmaceuticals

20 2Hainan Poly Pharm

21 5Holsten Pharma Gmbh

22 5Lunan Pharmaceutical

23 6Lupin Ltd

24 7MSN Laboratories

25 1Micro Labs Limited

26 5PharOS Ltd

27 6PharmaPath S.A.

28 1REGCON HOLDINGS

29 1Ravenbhel Pharma

30 15STADA Arzneimittel

31 9Sandoz B2B

32 5Sunshine Lake Pharma

33 5Swan Pond Investments Limited

34 1Tarbis Farma Sl

35 15Teva Pharmaceutical Industries

36 76UCB Pharma S.A

37 10Zentiva

38 5Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Brivaracetam

Brand Name : Brivaracetam Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date : 17-11-2025

Application Number : 90769

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Brivaracetam

Brand Name : Brivaracetam Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 17-11-2025

Application Number : 90767

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Brivaracetam

Brand Name : Brivaracetam Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 75MG

Packaging :

Approval Date : 17-11-2025

Application Number : 90771

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Brivaracetam

Brand Name : Brivaracetam Pensa

Dosage Form : Oral Solution

Dosage Strength : 10MG

Packaging :

Approval Date : 17-11-2025

Application Number : 90598

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Brivaracetam

Brand Name : Brivaracetam Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date : 17-11-2025

Application Number : 90768

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Brivaracetam

Brand Name : Brivaracetam Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 50MG

Packaging :

Approval Date : 17-11-2025

Application Number : 90770

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : APO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2538679

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : APO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 2538687

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : APO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2538695

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : APO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 75MG

Packaging :

Approval Date :

Application Number : 2538709

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

11

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : APO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2538717

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

12

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : AURO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2539292

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

13

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : AURO-BRIVARACETAM

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2539306

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

14

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2016-05-12

Application Number : 205836

Regulatory Info : RX

Registration Country : USA

blank

15

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : TABLET;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2016-05-12

Application Number : 205836

Regulatory Info : RX

Registration Country : USA

blank

16

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2016-05-12

Application Number : 205836

Regulatory Info : RX

Registration Country : USA

blank

17

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : TABLET;ORAL

Dosage Strength : 75MG

Packaging :

Approval Date : 2016-05-12

Application Number : 205836

Regulatory Info : RX

Registration Country : USA

blank

18

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 2016-05-12

Application Number : 205836

Regulatory Info : RX

Registration Country : USA

blank

19

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 50MG/5ML (10MG/ML)

Packaging :

Approval Date : 2016-05-12

Application Number : 205837

Regulatory Info : RX

Registration Country : USA

blank

20

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

BRIVARACETAM

Brand Name : BRIVIACT

Dosage Form : SOLUTION;ORAL

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2016-05-12

Application Number : 205838

Regulatory Info : RX

Registration Country : USA

blank